Anthropic IPO Listing: Claude maker debuts on Nasdaq at $111, up 33%, valuing it at over $2 trillion


Anthropic made a blockbuster debut on the Nasdaq on Thursday (November 19), with shares of the Claude maker opening at $111, against an issue price of $83 apiece, as investors rushed to get a piece of one of the world’s fastest-growing artificial intelligence companies. The stock opened 33% higher/lower than its IPO price, pushing the company’s value to over $2 trillion.

The much-anticipated listing marks a landmark moment for the AI industry, with Anthropic raising more than $81 billion in what has become a record-breaking initial public offering (IPO), surpassing SpaceX’s offering in June. The company sold 980 million shares at $83 apiece on Wednesday, after increasing both the size and price of its offering. Its fully diluted market capitalisation stood at approximately $1.5 trillion.

A record-breaking IPO puts AI back in the spotlight

The debut is being closely watched as a crucial test of investor appetite for artificial intelligence companies, particularly at a time when questions around lofty valuations, infrastructure spending and the long-term commercial viability of AI are coming into sharper focus. Anthropic’s opening performance could offer an important indication of how much confidence investors continue to place in the sector’s growth prospects.

The company will trade on the Nasdaq under the ticker symbol ‘ANT’. Its listing comes amid a period of heightened scrutiny for the AI trade. Investor concerns over Nvidia CEO Jensen Huang’s sudden ouster, voters’ strong rebuke of AI during the midterm elections and the sustainability of a multitrillion-dollar investment in AI infrastructure have added to uncertainty around the sector.

Claude’s maker rides a phenomenal growth wave

Founded in 2021 by Dario Amodei and his sister Daniela Amodei, alongside a group of former OpenAI researchers, Anthropic has rapidly emerged as one of the biggest names in the global AI race. Its Claude family of AI models and products has gained considerable traction among businesses, helping the five-year-old company deliver an extraordinary jump in revenue.

In its IPO prospectus, Anthropic reported revenue of $33.24 billion for the nine months ended September 30, representing a staggering 1,200% increase from the corresponding period last year. The growth underscores the pace at which demand for generative AI tools has expanded, particularly among corporate customers looking to integrate the technology into their operations.

Speaking at the listing event, CEO Dario Amodei offered a deeply personal account of why the company believes in AI’s potential to accelerate scientific discovery and medical research. Recalling how he and Daniela lost their father to a disease that became curable just two years later, he spoke about the time-consuming nature of medical research and the possibility of using AI to shorten that journey.

“We worked on tools that can cut through the long processes,” Amodei said, adding that AI could help accelerate the discovery of solutions and scientific research. He expressed hope that fewer families would have to endure the loss of loved ones when medical breakthroughs could potentially arrive just a few years earlier.

Amodei said medicine was only one example of how Claude could be put to use, pointing to its broader potential to strengthen democracies, lift economies and help pull people out of poverty.

The listing also brings renewed attention to the rivalry between Anthropic and OpenAI, the company from which Amodei and several researchers departed before establishing the Claude maker.

Also read: Anthropic IPO puts spotlight on AI valuations, spending and long-term returns

Safety concerns and regulation remain key challenges

However, Amodei was also candid about the risks associated with the technology, acknowledging that AI could be extremely dangerous if not developed responsibly. He said the risks were avoidable and stressed that safety remained central to Anthropic’s approach.

“Safety is in Anthropic’s DNA,” he said, adding that the company would not bend to pressure from either business interests or governments when it came to its safety principles, and would continue to prioritise responsible development.

Anthropic has faced criticism over its positions on AI safety, regulation and national security, including from US President Donald Trump and other senior government officials. These questions are likely to remain central to the company’s journey as it transitions from a privately held AI start-up to a publicly traded technology giant.

Speaking from the Nasdaq ahead of the opening bell, Anthropic President Daniela Amodei also addressed those apprehensive about the rapid advancement of artificial intelligence, urging them to have a say in how the technology evolves.

“This technology needs you — not your trust, not your use, but your voice,” she said. “The end of this story isn’t written yet. Intelligence is now something humans can build. What we choose to build with it is up to all of us.”

For Anthropic, Thursday’s debut is about more than just the money raised. Its ability to sustain growth, convert demand into long-term profitability and navigate mounting regulatory scrutiny will be closely monitored by public market investors.

In its prospectus, the company’s co-founders described their ambition as helping humanity navigate the technological transformation brought about by AI, while opening up new frontiers of discovery. They also positioned shareholders as participants in that broader mission.

Home/Market News/

Anthropic IPO Listing: Claude maker debuts on Nasdaq at $111, up 33%, valuing it at over $2 trillion



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *